1. Home
  2. MAN vs HRMY Comparison

MAN vs HRMY Comparison

Compare MAN & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ManpowerGroup

MAN

ManpowerGroup

SELL

Current Price

$41.52

Market Cap

2.5B

ML Signal

SELL

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

SELL

Current Price

$38.04

Market Cap

2.4B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MAN
HRMY
Founded
1948
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.4B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
MAN
HRMY
Price
$41.52
$38.04
Analyst Decision
Buy
Buy
Analyst Count
12
12
Target Price
★ $52.33
$48.25
AVG Volume (30 Days)
★ 991.7K
750.6K
Earning Date
10-15-2026
11-03-2026
Dividend Yield
★ 3.47%
N/A
EPS Growth
N/A
★ 7.97
EPS
1.19
★ 1.84
Revenue
★ $17,957,100,000.00
$868,453,000.00
Revenue This Year
$6.49
$18.62
Revenue Next Year
$3.49
$13.23
P/E Ratio
$34.81
★ $20.62
Revenue Growth
0.58
★ 21.51
52 Week Low
$25.15
$25.81
52 Week High
$63.88
$43.49

Technical Indicators

Market Signals
Indicator
MAN
HRMY
Relative Strength Index (RSI) 20.20 42.84
Support Level $29.25 $37.48
Resistance Level $57.29 $39.35
Average True Range (ATR) 2.52 1.28
MACD -1.23 -0.24
Stochastic Oscillator 3.93 50.52

Price Performance

Historical Comparison
MAN
HRMY

About MAN ManpowerGroup

ManpowerGroup Inc provides workforce solutions and services, including recruitment and assessment, upskilling, reskilling, training and development, career management, outsourcing, and workforce consulting. The company leverages its trusted brands, industry knowledge, and AI-enabled assessments and offers an extensive portfolio of training and leadership development solutions. Its reportable segments are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others, with Staffing and Interim generating the majority of revenue. It operates in the Americas, Southern Europe, Northern Europe, and APME. The company derives the maximum geographical revenue from the Southern European region.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: